Home / People / Dr. Christoph Lächler
Portrait ofChristoph Lächler

Dr. Christoph Lächler

Partner
Rechtsanwalt

CMS Hasche Sigle
Theodor-Heuss-Straße 29
70174 Stuttgart
Germany
Languages German, English, French

Christoph Lächler specialises in private equity and M&A transactions, advising German and international investors and companies on cross-border company acquisitions and sales, add-on transactions, joint ventures and other cooperation agreements. His clients include strategic investors as well as family equity investors. Christoph also has special expertise in the life sciences and healthcare sectors with a focus on advising on M&A transactions related to outpatient and inpatient services.

Christoph joined CMS in 2007 and was made partner in 2017. Alongside his legal practice, he has been a lecturer at Steinbeis School of International Business and Entrepreneurship since 2011.

more less

Listed for Corporate

Deutschlands beste Anwälte 2023 – Handelsblatt in Kooperation mit Best Lawyers

"Very competent, quick-reacting contact persons, especially Christoph Lächler, who has very sound legal knowledge and uses it optimally.", client

The Legal 500 EMEA, 2022

Leading lawyer for mergers & acquisitions

Kanzleimonitor 2021, 2022

Leading lawyer for mergers & acquisitions

Kanzleimonitor 2020, 2021

"Very competent, quick-reacting contact persons, especially Christoph Lächler, who has very sound legal knowledge and uses it optimally.", client

The Legal 500 EMEA, 2022

Publications

  • “Getting the Deal Through: Healthcare M&A, Country Report Germany, September 2019, Law Business Research Ltd.” (together with Dr Roland Wiring und Daniel Mahn)
  • Familienverfassung und Family Governance, in: von Rechenberg/Thies/Wiechers (Hrsg.), Handbuch Familienunternehmen und Unternehmerfamilien, Stuttgart 2016
  • Kommentierung zum SE-Konzernrecht, in: Lutter/Hommelhoff/Teichmann (Hrsg.), SE-Kommentar, 2. Aufl., Köln, 2015 (together with Prof. Dr Dr h.c. mult. Peter Hommelhoff)
  • Förder- und Schutzrecht für den SE-Konzern, AG 2014, p. 257 ff. (together with Prof. Dr Dr h.c. mult. Peter Hommelhoff)
  • Das Konzernrecht der Europäischen Gesellschaft (SE): Unter besonderer Berücksichtigung der Mitgliedstaaten Deutschland, Frankreich, England und Polen 2007, Baden-Baden
  • Funktion und Umfang des Regelungsbereichs der SE-Verordnung, NZG 2005, p. 381 ff. (together with K. Oplustil)
more less

Education

  • 2007: Second state examination in law
  • Trainee lawyer at Ellwangen Regional Court including placements in Stuttgart and New York
  • PhD; thesis on the group law of the Societas Europaea (SE) under the supervision of Prof. Dr. Dr. Dres. h.c. Peter Hommelhoff, European Post Graduate Programme at the University of Heidelberg
  • 2003: First state examination in law
  • Law and economics studies at the University of Heidelberg
more less

Feed

21/02/2024
CMS advises MVZ Laaff on sale to amedes
Stuttgart – The founder of medical laboratory MVZ Laaff, Prof. Helmut Laaff, has sold MVZ Laaff GmbH with its facilities in Freiburg, Heilbronn and Ulm to the amedes Group. amedes is a leading German lab services provider, operating a number of healthcare centres throughout Germany with different specialisations. MVZ Laaff provides services in fields of medicine including derma­to­path­o­logy, general pathology, immunohistology, molecular pathology and cytology, and is one of the leading laboratories in these specialist areas. Details of the transaction were not disclosed.A CMS team headed by lead partner Dr Christoph Lächler advised Prof. Helmut Laaff on all legal aspects of the transaction. The sale took place by way of an auction process. A particular focus of the advice was on structuring the transaction and the associated regulatory issues. CMS Germany Dr Christoph Lächler, Lead Part­ner Stefan-Ul­rich Müller, Partner Dr Jacob Siebert, Partner Viktoria Barthel, Senior Associate Tobias Kalski, Senior As­so­ci­ate An­dreas Kazmaier, Associate, all Corporate/M&A Dr Roland Wiring, Partner Dr Siham Hidar, Senior Associate, both Regulatory Dr Harald Kahlenberg, Partner Angelika Wieczorkowski, Senior Associate, both Antitrust, Competition & Trade Dr Stefan Voss, Partner Lukas Potstada, Counsel, both Real Estate Dr Martin Mohr, Partner, TaxPress Con­tact presse@cms-hs. com
14/08/2023
CMS advises SYNLAB on sale of Veterinary Diagnostics business to Mars
Stuttgart – The SYNLAB Group, a leading provider of medical diagnostic services and specialist tests in Europe, has sold its Veterinary Diagnostics business (SYNLAB VET) to a subsidiary of US group...
02/06/2023
CMS advises SYNLAB on acquisition of WolfartKlinik
Stuttgart – The SYNLAB Group has acquired the WolfartKlinik hospital in Gräfelfing near Munich from the Wolfart family. The transaction was agreed in February 2023 and has now been successfully completed...
29/09/2022
CMS advises AEW on investment in Mobility as a Service provider AZOWO
Stuttgart – Mobility as a Service provider AZOWO GmbH has raised growth capital in a Series A financing round led by AEW Energie AG (AEW).A CMS team headed by Dr Christoph Lächler and Dr Florian Plagemann...
28/01/2022
CMS advises DermaZentrum on sale to Halder
Stuttgart – The founder of the DermaZentrum Group, Prof. Viktor Meineke, has sold a majority stake in the group to private equity firm Halder as part of an owner buy-out. The transaction has now been...
03/11/2020
CMS advises private equity firm Seafort Advisors on sale of Noventiz Group
Stuttgart – Private equity firm Seafort Advisors is selling the Noventiz Group, a certified waste management company and provider of packaging compliance services. The buyer is Reconomy Ltd., a leading...
26/06/2020
Apotal Group sells online pharmacy’s mail-order business and diabetes arm...
Stuttgart – Company founder Heinz-Peter Fichter and other shareholders have sold the mail-order business of online pharmacy Apotal and its diabetes division to the listed Zur Rose Group of Switzerland...
04/10/2019
Healthcare M&A
Getting the Deal Through – Healthcare M&A explores the main issues in healthcare M&A transactions. It also acts as a comparative legal guide for cross border or multi-jur­is­dic­tion­al activities and a...
27/09/2018
CMS advises ElringKlinger on sale of stake in new enerday
Stuttgart – ElringKlinger AG has sold its shareholding in new enerday GmbH to Dresden-based Sunfire GmbH. new enerday specialises in high-temperature SOFC (Solid Oxide Fuel Cell) technology. The parties...
16/08/2018
CMS advises the Koller family on the sale of the Hoegger Group to Provisur...
The Hoegger Group, headquartered in Switzerland and with subsidiaries located in Germany and the USA, has joined forces with Provisur Technologies, Chicago / USA. Both the Hoegger Group and Provisur are...
01/08/2018
NEXTCLINICS advised by CMS team on acquisition of IVF-Zentren Prof. ZECH,...
Stuttgart – NEXTCLINICS INTERNATIONAL GmbH has acquired IVF-Zentren Prof. ZECH, a group of private clinics specialising in reproductive medicine. The transaction is currently awaiting approval from...
17/07/2018
CMS advises IT consulting group NTT DATA on acquisition of dealer management...
Stuttgart – NTT DATA EMEA Ltd., part of IT service provider NTT DATA, has acquired automotive sales and after-sales specialist gen-ius dms GmbH. The parties agreed not to disclose details of the purchase...